Glucose Intolerance in Patients With Cystic Fibrosis: Sex-Based Differences in Clinical Score, Pulmonary Function, Radiograph Score, and 6-Minute Walk Test

References

1. 1.↵
   1. Costa M,
   2. Potvin S,
   3. Hammana I,
   4. Malet A,
   5. Berthiaume Y,
   6. Jeanneret A,
   7. et al

   . Increased glucose excursion in cystic fibrosis and its association with a worse clinical status. J Cyst Fibros 2007;6(6):376–383.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Lombardo F,
   2. De Luca F,
   3. Rosano M,
   4. Sferlazzas C,
   5. Lucanto C,
   6. Arrigo T,
   7. et al

   . Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003;149:53–59.

   OpenUrlAbstract
3. 3.↵
   1. Marshall BC,
   2. Butler SM,
   3. Stoddard M,
   4. Moran AM,
   5. Liou TG,
   6. Morgan WJ

   . Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005;146(5):681–687.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Moran A,
   2. Hardin D,
   3. Rodman D,
   4. Allen HF,
   5. Beall RJ,
   6. Borowitz D,
   7. et al

   . Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999;45(1):61–73.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Koch C,
   2. Rainisio M,
   3. Madessani U,
   4. Harms HK,
   5. Hodson ME,
   6. Mastella G,
   7. et al

   . Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European epidemiologic registry of cystic fibrosis. Pediatr Pulmonol 2001;32(5):343–350.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Lanng S,
   2. Hansen A,
   3. Thorsteinsson B,
   4. Nerup J,
   5. Koch C

   . Glucose tolerance in patients with cystic fibrosis: five year prospective study. BMJ 1995;311(7006):655–659.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Lands LC,
   2. Heigenhauser GJ,
   3. Jones NL

   . Analysis of factors limiting maximal exercise performance in cystic fibrosis. Clin Sci (Lond) 1992;83(4):391–397.

   OpenUrlPubMed
8. 8.
   1. Shah AR,
   2. Gozal D,
   3. Keens TG

   . Determinants of aerobic and anaerobic exercise performance in cystic fibrosis. Am J Respir Crit Care Med 1998;157(4 Pt 1):1145–1150.

   OpenUrlPubMedWeb of Science
9. 9.↵
   1. Ziegler B,
   2. Rovedder PM,
   3. Oliveira CL,
   4. Schuh SJ,
   5. Silva FA,
   6. Dalcin Pde T

   . Predictors of oxygen desaturation during the six-minute walk test in patients with cystic fibrosis. J Bras Pneumol 2009;35(10):957–965.

   OpenUrlPubMed
10. 10.↵
    American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–117.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Brennan AL,
    2. Geddes DM,
    3. Gyi KM,
    4. Baker EH

    . Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004;3(4):209–222.

    OpenUrlCrossRefPubMed
12. 12.
    1. Finkelstein SM,
    2. Wielinski CL,
    3. Elliott GR,
    4. Warwick WJ,
    5. Barbosa J,
    6. Wu SC,
    7. Klein DJ

    . Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988;112(3):373–377.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Milla CE,
    2. Warwick WJ,
    3. Moran A

    . Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000;162(3 Pt 1):891–895.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.
    1. Rolon MA,
    2. Benali K,
    3. Munck A,
    4. Navarro J,
    5. Clement A,
    6. Tubiana-Rufi N,
    7. et al

    . Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001;90(8):860–867.

    OpenUrlPubMedWeb of Science
15. 15.↵
    1. Rosenecker J,
    2. Eichler I,
    3. Bärmeier H,
    4. von der Hardt H

    . Diabetes mellitus and cystic fibrosis: comparison of clinical parameters in patients treated with insulin versus oral glucose-lowering agents. Pediatr Pulmonol 2001;32(5):351–355.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Demko CA,
    2. Byard PJ,
    3. Davis PB

    . Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 1995;48(8):1041–1049.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Aurora P,
    2. Wade A,
    3. Whitmore P,
    4. Whitehead B

    . A model for predicting life expectancy of children with cystic fibrosis. Eur Respir J 2000;16(6):1056–1060.

    OpenUrlAbstract
18. 18.↵
    1. Allen JR,
    2. McCauley JC,
    3. Selby AM,
    4. Waters DL,
    5. Gruca MA,
    6. Baur LA,
    7. et al

    . Differences in resting energy expenditure between male and female children with cystic fibrosis. J Pediatr 2003;142(1):15–19.

    OpenUrlCrossRefPubMedWeb of Science
19. 19.↵
    1. Sims EJ,
    2. Green MW,
    3. Mehta A

    . Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes. Diabetes Care 2005;28(7):1581–1587.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Milla CE,
    2. Billings J,
    3. Moran A

    . Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis. Diabetes Care 2005;28(9):2141–2144.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Rosenstein BJ,
    2. Cutting GR

    ; Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132(4):589–595.

    OpenUrlCrossRefPubMedWeb of Science
22. 22.↵
    1. Shwachman H,
    2. Kulczycki LL

    . Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. AMA J Dis Child 1958;96(1):6–15.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. Borowitz D,
    2. Baker RD,
    3. Stallings V

    . Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002;35(3):246–259.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Sinaasappel M,
    2. Stern M,
    3. Littlewood J,
    4. Wolfe S,
    5. Steinkamp G,
    6. Heijerman HG,
    7. et al

    . Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1(2):51–75.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Miller MR,
    2. Hankinson J,
    3. Brusasco V,
    4. Burgos F,
    5. Casaburi R,
    6. Coates A,
    7. et al

    ; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26(2):319–338.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Brasfield D,
    2. Hicks G,
    3. Soong S,
    4. Tiller RE

    . The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979;63(1):24–29.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2007;30(Suppl 1):S42–S47.

    OpenUrlFREE Full Text
28. 28.↵
    1. Enright PL,
    2. Sherrill DL

    . Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384–1387.

    OpenUrlCrossRefPubMedWeb of Science
29. 29.↵
    1. Li AM,
    2. Yin J,
    3. Au JT,
    4. So HK,
    5. Tsang T,
    6. Wong E,
    7. et al

    . Standard reference for the six-minute-walk test in healthy children aged 7 to 16 years. Am J Respir Crit Care Med 2007;176(2):174–180.

    OpenUrlCrossRefPubMedWeb of Science
30. 30.↵
    1. Sheehan-Holt JK

    . MANOVA simultaneous test procedures: the power and robustness of restricted multivariate contrasts. Educ Phychol Meas 1998;58:861–881.

    OpenUrl
31. 31.↵
    1. Choo-Kang LR,
    2. Zeitlin PL

    . Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy Curr Opin Pulm Med 2000;6(6):521–529.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Garagorri JM,
    2. Rodríguez G,
    3. Ros L,
    4. Sánchez A

    . Early detection of impaired glucose tolerance in patients with cystic fibrosis and predisposition factors. J Pediatr Endocrinol Metab 2001;14(1):53–60.

    OpenUrlPubMedWeb of Science
33. 33.↵
    1. Tofé S,
    2. Moreno J,
    3. Máiz L,
    4. Alonso M,
    5. Escobar H,
    6. Barrio R

    . Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. Eur J Endocrinol 2005;152(2):241–247.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Elder DA,
    2. Wooldridge JL,
    3. Dolan LM,
    4. D'Alessio DA

    . Glucose tolerance, insulin secretion, and insulin sensitivity in children and adolescents with cystic fibrosis and no prior history of diabetes. J Pediatr 2007;151(6):653–658.

    OpenUrlCrossRefPubMedWeb of Science
35. 35.↵
    1. Solomon MP,
    2. Wilson DC,
    3. Corey M,
    4. Kalnins D,
    5. Zielenski J,
    6. Tsui LC,
    7. et al

    . Glucose intolerance in children with cystic fibrosis. J Pediatr 2003;142(2):128–132.

    OpenUrlCrossRefPubMedWeb of Science